Paul H McClelland
Overview
Explore the profile of Paul H McClelland including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
44
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Johnson R, McClelland P, Ahmad S
Surg Clin North Am
. 2024 Sep;
104(5):987-1005.
PMID: 39237173
While pancreatic adenocarcinoma requires surgical resection definitive cure, treatment paradigms are shifting toward a neoadjuvant approach to systemic therapy. Rationale is twofold: micro-metastatic disease is likely present in a majority...
2.
McClelland P, Gregory S, Nah S, Hernandez J, Davis J, Blakely A
Ann Surg Oncol
. 2024 Jun;
31(9):6237-6251.
PMID: 38874874
Background: Mucinous adenocarcinoma of the appendix (MACA) follows a complex disease course with variable survival. Large-scale predictive modeling may determine subtle yet important prognostic factors otherwise unseen in smaller cohort...
3.
Ryan C, Fasaye G, Gallanis A, Gamble L, McClelland P, Duemler A, et al.
JAMA
. 2024 Jun;
332(9):722-729.
PMID: 38873722
Importance: Approximately 1% to 3% of gastric cancers and 5% of lobular breast cancers are hereditary. Loss of function CDH1 gene variants are the most common gene variants associated with...
4.
McClelland P, Blakely A
Ann Surg Oncol
. 2024 Jun;
31(9):6278-6279.
PMID: 38862838
No abstract available.
5.
Gamble L, McClelland P, Teke M, Samaranayake S, Juneau P, Famiglietti A, et al.
NPJ Breast Cancer
. 2023 Oct;
9(1):87.
PMID: 37872305
No abstract available.
6.
Gamble L, McClelland P, Teke M, Samaranayake S, Juneau P, Famiglietti A, et al.
NPJ Breast Cancer
. 2023 Sep;
9(1):77.
PMID: 37758801
Women with germline pathogenic variants in CDH1, which encodes E-cadherin protein, are at increased lifetime risk of invasive lobular carcinoma (ILC). The associated tumor characteristics of hereditary lobular breast carcinoma...
7.
McClelland P, Jawed M, Kabata K, Zenilman M, Gorecki P
Surg Endosc
. 2023 Sep;
37(12):9427-9440.
PMID: 37676323
Background: Laparoscopic Roux-en-Y gastric bypass (LRYGB) is the gold-standard bariatric procedure with proven efficacy in morbidly obese populations. While the short-term benefits of LRYGB have been well-documented, durable weight loss...
8.
Cho E, Zenilman M, McClelland P, Rodriguez D, Steele J, Fahoum B, et al.
Surg Open Sci
. 2022 Oct;
10:156-157.
PMID: 36248182
We describe a straightforward model to implement a high volume specialty surgery program at a community hospital. Using pancreatic surgery as an example, we employed published processes in three arenas....
9.
McClelland P, Kabata K, Gorecki W, Jano A, Zenilman M, Gorecki P
Surg Endosc
. 2022 Aug;
37(3):2416.
PMID: 36001154
No abstract available.
10.
McClelland P, Kabata K, Gorecki W, Jano A, Zenilman M, Gorecki P
Surg Endosc
. 2022 Jul;
37(3):2224-2238.
PMID: 35879574
Background: Obesity is a public health concern among adolescents and young adults. Bariatric surgery is the most effective treatment for morbid obesity and has been increasingly utilized in young patients....